November 14, 2021
We all looked very much forward to the upcoming Dutch Life Sciences conference on November 25th.
Unfortunately we have to inform you that due to the Dutch Government rules to prevent the spread of COVID-19, it is currently not possible to continue our event on the scheduled date.
November 10, 2021
Corporate governance structure for start-ups should identify roles, authority, and timing in key business decisions between shareholders, directors, and the CEO. But if there is a lack of governance structure across the business it could have a negative impact on the success of the company. For instance it could be much harder to attract funding from investors.
October 15, 2021
Changes to the healthcare systems over the last few years have made market access, pricing and reimbursement critical in driving prescriptions and ultimately sales revenue. In addition to structural changes in the healthcare systems, the dynamics of patients, healthcare policy makers and payer behaviour have altered significantly. The environment is becoming more complex, with a significant shift in the relative importance and roles of key stakeholder groups.
September 28, 2021
In 2021, two editions of the Venture Challenge took place: in the summer and in the fall. Ten innovative Life Sciences & Health startups participated in the programme. The teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case. The winner of both editions will be announced during the Dutch Life Science Conference.
September 24, 2021
Developing and commercializing a new life sciences product or service requires meticulous research, planning, strategy and management. It often encompasses different goals than research and grant funding. There are several necessary steps, and a strategy needs to be well defined in order to be successful. Product development requires input from and between various groups within a company and, for academia, outside entities.
August 23, 2021
For healthcare products that require clinical studies to support licensing or regulatory clearance the execution of the clinical plan is the most critical stage in the product development process of a company. For young companies the success of a clinical study is very crucial and determines if the company is able to continue its product development program and eventually get market approval by the regulatory organisations such as the FDA and EMA.
June 15, 2021
Thanks to our Startup Supporter V.O. Patents & Trademarks, we are very pleased that we can offer 10 free tickets for Startup companies. Available for companies younger than 2 years.
December 14, 2020
Link to recorded livestream and presentations 2020 conference.